{"organizations": [], "uuid": "2ea874237adbe629a67babb2b641c58346289422", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-nuvo-pharmaceuticals-acquires-glob/brief-nuvo-pharmaceuticals-acquires-global-ex-u-s-product-rights-existing-royalty-streams-to-resultz-from-piedmont-pharmaceuticals-idUSASB0BZEK", "country": "US", "domain_rank": 408, "title": "BRIEF-Nuvo Pharmaceuticals Acquires Global Ex-U.S. Product Rights, Existing Royalty Streams To Resultz From Piedmont Pharmaceuticals", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-02T14:39:00.000+02:00", "replies_count": 0, "uuid": "2ea874237adbe629a67babb2b641c58346289422"}, "author": "", "url": "https://www.reuters.com/article/brief-nuvo-pharmaceuticals-acquires-glob/brief-nuvo-pharmaceuticals-acquires-global-ex-u-s-product-rights-existing-royalty-streams-to-resultz-from-piedmont-pharmaceuticals-idUSASB0BZEK", "ord_in_thread": 0, "title": "BRIEF-Nuvo Pharmaceuticals Acquires Global Ex-U.S. Product Rights, Existing Royalty Streams To Resultz From Piedmont Pharmaceuticals", "locations": [], "entities": {"persons": [], "locations": [{"name": "piedmont", "sentiment": "none"}], "organizations": [{"name": "resultz from piedmont pharmaceuticals", "sentiment": "negative"}, {"name": "nuvo", "sentiment": "none"}, {"name": "resultz from piedmont pharmaceuticals reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "nuvo pharmaceuticals inc", "sentiment": "none"}, {"name": "pharmaceuticals llc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 2, 2018 / 12:41 PM / Updated 34 minutes ago BRIEF-Nuvo Pharmaceuticals Acquires Global Ex-U.S. Product Rights, Existing Royalty Streams To Resultz From Piedmont Pharmaceuticals Reuters Staff 1 Min Read \nJan 2 (Reuters) - Nuvo Pharmaceuticals Inc: \n* NUVO PHARMACEUTICALS INC.™ ACQUIRES GLOBAL EX-U.S. PRODUCT RIGHTS AND EXISTING ROYALTY STREAMS TO RESULTZ® FROM PIEDMONT PHARMACEUTICALS LLC \n* NUVO PHARMACEUTICALS INC - ‍UNDER TERMS OF AGREEMENT, NUVO HAS PAID US$7.0 MILLION ON CLOSE TO PIEDMONT​ \n* NUVO PHARMACEUTICALS INC - ‍IMMEDIATELY ACCRETIVE ACQUISITION​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-02T14:39:00.000+02:00", "crawled": "2018-01-02T14:54:12.000+02:00", "highlightTitle": ""}